[PDF][PDF] New insights into diagnosis and therapeutic options for proliferative hepatoblastoma
KB Hooks, J Audoux, H Fazli, S Lesjean, T Ernault… - …, 2018 - Wiley Online Library
Surgery and cisplatin‐based treatment of hepatoblastoma (HB) currently guarantee the
survival of 70%‐80% of patients. However, some important challenges remain in diagnosing …
survival of 70%‐80% of patients. However, some important challenges remain in diagnosing …
New insights into diagnosis and therapeutic options for proliferative hepatoblastoma
KB Hooks, J Audoux, H Fazli, S Lesjean, T Ernault… - Hepatology, 2018 - hero.epa.gov
Surgery and cisplatin-based treatment of hepatoblastoma (HB) currently guarantee the
survival of 70%-80% of patients. However, some important challenges remain in diagnosing …
survival of 70%-80% of patients. However, some important challenges remain in diagnosing …
New insights into diagnosis and therapeutic options for proliferative hepatoblastoma
KB Hooks, J Audoux, H Fazli, S Lesjean, T Ernault… - Hepatology, 2018 - journals.lww.com
Surgery and cisplatin‐based treatment of hepatoblastoma (HB) currently guarantee the
survival of 70%‐80% of patients. However, some important challenges remain in diagnosing …
survival of 70%‐80% of patients. However, some important challenges remain in diagnosing …
New insights into diagnosis and therapeutic options for proliferative hepatoblastoma
KB Hooks, J Audoux, H Fazli, S Lesjean, T Ernault… - Hepatology, 2017 - hal.science
Surgery and cisplatin-based treatment of hepatoblastoma (HB) currently guarantee the
survival of 70-80% of patients. However, some important challenges remain in diagnosing …
survival of 70-80% of patients. However, some important challenges remain in diagnosing …
New insights into diagnosis and therapeutic options for proliferative hepatoblastoma.
KB Hooks, J Audoux, H Fazli, S Lesjean… - Hepatology …, 2018 - europepmc.org
Conclusion The highly proliferating C2A subtype is characterized by topoisomerase 2-alpha
gene up-regulation and FA pathway activation, and the HB therapeutic arsenal could …
gene up-regulation and FA pathway activation, and the HB therapeutic arsenal could …
[引用][C] New insights into diagnosis and therapeutic options for proliferative hepatoblastoma
KB Hooks, J Audoux, H Fazli, S Lesjean, T Ernault… - Hepatology, 2018 - cir.nii.ac.jp
New insights into diagnosis and therapeutic options for proliferative hepatoblastoma | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
New insights into diagnosis and therapeutic options for proliferative hepatoblastoma
KB Hooks, J Audoux, H Fazli… - Hepatology …, 2018 - pubmed.ncbi.nlm.nih.gov
Surgery and cisplatin-based treatment of hepatoblastoma (HB) currently guarantee the
survival of 70%-80% of patients. However, some important challenges remain in diagnosing …
survival of 70%-80% of patients. However, some important challenges remain in diagnosing …
New insights into diagnosis and therapeutic options for proliferative hepatoblastoma
KB Hooks, J Audoux, H Fazli, S Lesjean, T Ernault… - …, 2017 - inserm.hal.science
Surgery and cisplatin-based treatment of hepatoblastoma (HB) currently guarantee the
survival of 70-80% of patients. However, some important challenges remain in diagnosing …
survival of 70-80% of patients. However, some important challenges remain in diagnosing …
[PDF][PDF] New Insights Into Diagnosis and Therapeutic Options for Proliferative Hepatoblastoma
KB Hooks, J Audoux, H Fazli, S Lesjean, T Ernault… - …, 2018 - academia.edu
Surgery and cisplatin-based treatment of hepatoblastoma (HB) currently guarantee the
survival of 70%-80% of patients. However, some important challenges remain in diagnosing …
survival of 70%-80% of patients. However, some important challenges remain in diagnosing …